Abstract
Background
This study aims to systematically evaluate the current landscape of artificial intelligence (AI) and machine learning applications in lymphedema research by employing bibliometric and altmetric analyses. The goal is to identify major trends, research focuses, and influential contributors in this rapidly evolving field.
Method
A total of 43 AI-related articles on lymphedema published between 1975 and 2025 were retrieved from the Web of Science Core Collection. Bibliometric indicators such as publication years, journals, countries, authorship, and citation metrics were analyzed. Altmetric scores were also assessed. Each study was classified by study type and thematic focus.
Result
Original research articles constituted the majority (n = 26), with clinical studies being the most common subtype. The United States and China led in publication output. Most studies were published in Q1-Q2 journals, indicating high scientific quality. Scientific Reports was the most productive journal. General AI applications and risk prediction emerged as dominant themes. A moderate positive correlation was found between average annual citations and altmetric scores (r = 0.470, p = 0.039), suggesting consistency between academic impact and online visibility.
Conclusion
This is the first study to comprehensively map AI-based research in the field of lymphedema using bibliometric and altmetric methods. The findings reveal increasing global interest and high-impact publications, particularly in the domains of risk prediction and early diagnosis. These insights may guide future methodological frameworks and interdisciplinary collaborations in this emerging field.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
